The Use of Modified Templates in Early and Advanced Stage Nonseminomatous Germ Cell Tumor
Advances in Urology · 2018 · 2018 · 1-5
DOI: 10.1155/2018/6783147 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Urology, 2018. Verfasst von Timothy A Masterson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The surgical management of both early and advanced stage germ cell tumors of the testis remains a complex process of surgical decision making to maximize oncologic control while minimizing morbidity. Over the past 5 decades, the evolution of the surgical template for retroperitoneal lymphadenectomy (RPLND) has resulted in important modifications to achieve these goals. In this review, we will characterize the historical motivating factors that led to the modified template, outline patient and clinical factors in selecting these approaches in both early and advanced stage disease, and briefly discuss future horizons for their implementation.
Autor:innen und Institutionen
- Department of Urology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
ORCID-Profile: Timothy A Masterson
Zitieren
APA
Masterson, T. A., & Cary, C. (2018). The Use of Modified Templates in Early and Advanced Stage Nonseminomatous Germ Cell Tumor. Advances in Urology, 2018, 1-5. https://doi.org/10.1155/2018/6783147
Vancouver
Masterson TA, Cary C. The Use of Modified Templates in Early and Advanced Stage Nonseminomatous Germ Cell Tumor. Advances in Urology. 2018;2018:1-5. doi:10.1155/2018/6783147
BibTeX
@article{Masterson2018,
author = {Masterson, Timothy A and Cary, Clint},
title = {The Use of Modified Templates in Early and Advanced Stage Nonseminomatous Germ Cell Tumor},
journal = {Advances in Urology},
year = {2018},
volume = {2018},
pages = {1--5},
doi = {10.1155/2018/6783147}
}
EUVIMED